RHI
57
-6
ABT
59
2
GME
66
-5
ROP
53
-9
RIG
43
-7
MTCH
20
-8
CAG
24
-3
AIV
64
4
ED
45
3
HPE
44
-2
NOV
52
-5
MUR
44
-3
FSLR
44
-2
RSG
65
-3
MMM
35
-5
URI
60
-6
MU
28
-3
AVGO
18
-9
TXN
43
-5
ROST
57
-3
RHI
57
-6
ABT
59
2
GME
66
-5
ROP
53
-9
RIG
43
-7
MTCH
20
-8
CAG
24
-3
AIV
64
4
ED
45
3
HPE
44
-2
NOV
52
-5
MUR
44
-3
FSLR
44
-2
RSG
65
-3
MMM
35
-5
URI
60
-6
MU
28
-3
AVGO
18
-9
TXN
43
-5
ROST
57
-3
Financhill
Back

Nuveen Preferred and Income Term Fund Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
8

JPI
Nuveen Preferred and Income Term Fund

Last Price:
20.35
Seasonality Move:
1.67%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
8
Nuveen Preferred and Income Term Fund (JPI) is a Sell

Is Nuveen Preferred and Income Term Fund a Buy, Sell or Hold?

  • The current Nuveen Preferred and Income Term Fund [JPI] share price is $20.39. The Score for JPI is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • JPI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JPI Stock Price Chart

What is Nuveen Preferred and Income Term Fund's stock price today?

  • The Nuveen Preferred and Income Term Fund share price today is $20.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JPI is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

JPI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 36.92 Sell
Chaikin Money Flow: 17427 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.79 - 21.21) Sell
Bollinger Bands (100): (19.52 - 20.86) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

JPI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.87 Sell
20-day SMA: 21 Sell
50-day SMA: 20.73 Sell
200-day SMA: 19.61 Buy
8-day EMA: 20.79 Sell
20-day EMA: 20.9 Sell
50-day EMA: 20.7 Sell
200-day EMA: 19.71 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Nuveen Preferred and Income Term Fund Earnings Growth & JPI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Nuveen Preferred and Income Term Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):